Conmed (CNMD) Tops Q1 EPS by 9c; Raises Outlook
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $32.15 -1.32%
EPS Growth %: -3.5%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -3.5%
Financial Fact:
Total operating expenses: 87.36M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q1 EPS of $0.53, $0.09 better than the analyst estimate of $0.44. Revenue for the quarter came in at $202.1 million versus the consensus estimate of $196.4 million.
GUIDANCE:
Conmed raises FY2018 EPS to $2.15-$2.20, versus the consensus of $2.14.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
